April 16, 2025 Nvidia’s $5.5B AI Chip Crunch and ASML’s Tariff Jitters
Tesla: Rebound Signals Strength Amid Economic Shifts
3M: Evaluating Challenges to Portfolio Resilience
April 23, 2025 Oleksandr Orlovskyi: Reviews, Biography, and All About Cryptocurrency
March 12, 2025 Features of exchanging USDC ERC20 to Bank Transfer
February 19, 2025 Why Stock Caps Matter When Building a Diversified Portfolio
February 5, 2025 Top 5 Coins for the Maximum Passive Income from Staking by 2024
January 21, 2025 Trading Stocks With AI: A Modern Approach
Altamira Therapeutics (CYTO) Stock Forecast for 2025, 2026, 2027. Sell or Buy?
Updated: April 24, 2025 (22:46)
Sector: HealthcareThe share price of Altamira Therapeutics Ltd. (CYTO) now
Are you interested in Altamira Therapeutics Ltd. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Altamira Therapeutics stock price in 2025, 2026, 2027. How much will one Altamira Therapeutics share be worth in 2025 - 2027?
When should I take profit in Altamira Therapeutics stock? When should I record a loss on Altamira Therapeutics stock? What are analysts' forecasts for Altamira Therapeutics stock? What is the future of Altamira Therapeutics stock? We forecast Altamira Therapeutics stock performance using neural networks based on historical data on Altamira Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Altamira Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Altamira Therapeutics shares. This happens once a day.
Historical and forecast chart of Altamira Therapeutics stock
The chart below shows the historical price of Altamira Therapeutics stock and a prediction chart for the next month.
For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast,
and Weighted Average Best Forecast. Detailed values for the Altamira Therapeutics stock price can be found in the table below.
Long-term forecasts by years.
Altamira Therapeutics Ltd is committed to the development of therapeutic agents to address unmet medical needs. It is active in the treatment of RNA, allergies and viral infections, as well as in diseases of the inner ear. Bentrio is a drug-free nasal spray for personal protection against airborne viruses and allergens.
Altamira Therapeutics daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Apr 26 | 0.30 | 0.28 | 0.30 | 6.62 |
| Apr 27 | 0.29 | 0.29 | 0.30 | 5.65 |
| Apr 28 | 0.29 | 0.28 | 0.29 | 3.92 |
| Apr 29 | 0.29 | 0.28 | 0.30 | 7.78 |
| Apr 30 | 0.29 | 0.28 | 0.30 | 5.62 |
| May 01 | 0.30 | 0.29 | 0.31 | 7.38 |
| May 02 | 0.31 | 0.29 | 0.32 | 8.94 |
| May 03 | 0.30 | 0.30 | 0.31 | 5.30 |
| May 04 | 0.30 | 0.29 | 0.31 | 6.04 |
| May 05 | 0.29 | 0.28 | 0.29 | 3.56 |
| May 06 | 0.28 | 0.26 | 0.28 | 6.61 |
| May 07 | 0.29 | 0.27 | 0.29 | 6.13 |
| May 08 | 0.29 | 0.28 | 0.29 | 4.74 |
| May 09 | 0.30 | 0.29 | 0.30 | 4.86 |
| May 10 | 0.30 | 0.28 | 0.31 | 9.30 |
| May 11 | 0.31 | 0.30 | 0.32 | 6.70 |
| May 12 | 0.32 | 0.31 | 0.33 | 7.93 |
| May 13 | 0.32 | 0.30 | 0.33 | 7.30 |
| May 14 | 0.30 | 0.30 | 0.31 | 4.14 |
| May 15 | 0.29 | 0.29 | 0.30 | 5.42 |
| May 16 | 0.30 | 0.29 | 0.30 | 4.01 |
| May 17 | 0.30 | 0.29 | 0.31 | 5.17 |
| May 18 | 0.32 | 0.31 | 0.32 | 5.23 |
| May 19 | 0.32 | 0.31 | 0.33 | 6.38 |
| May 20 | 0.32 | 0.32 | 0.33 | 3.66 |
| May 21 | 0.32 | 0.31 | 0.33 | 7.64 |
| May 22 | 0.30 | 0.30 | 0.31 | 3.60 |
| May 23 | 0.31 | 0.30 | 0.32 | 5.05 |
| May 24 | 0.29 | 0.29 | 0.30 | 4.95 |
| May 25 | 0.29 | 0.28 | 0.30 | 7.40 |
Altamira Therapeutics Daily Price Targets
Altamira Therapeutics Stock Forecast 04-26-2025.
Forecast target price for 04-26-2025: $0.30.
Negative dynamics for Altamira Therapeutics shares will prevail with possible volatility of 6.207%.
Pessimistic target level: 0.28
Optimistic target level: 0.30
Altamira Therapeutics Stock Forecast 04-27-2025.
Forecast target price for 04-27-2025: $0.29.
Negative dynamics for Altamira Therapeutics shares will prevail with possible volatility of 5.350%.
Pessimistic target level: 0.29
Optimistic target level: 0.30
Altamira Therapeutics Stock Forecast 04-28-2025.
Forecast target price for 04-28-2025: $0.29.
Negative dynamics for Altamira Therapeutics shares will prevail with possible volatility of 3.772%.
Pessimistic target level: 0.28
Optimistic target level: 0.29
Altamira Therapeutics Stock Forecast 04-29-2025.
Forecast target price for 04-29-2025: $0.29.
Negative dynamics for Altamira Therapeutics shares will prevail with possible volatility of 7.222%.
Pessimistic target level: 0.28
Optimistic target level: 0.30
Altamira Therapeutics Stock Forecast 04-30-2025.
Forecast target price for 04-30-2025: $0.29.
Positive dynamics for Altamira Therapeutics shares will prevail with possible volatility of 5.325%.
Pessimistic target level: 0.28
Optimistic target level: 0.30
Altamira Therapeutics Stock Forecast 05-01-2025.
Forecast target price for 05-01-2025: $0.30.
Positive dynamics for Altamira Therapeutics shares will prevail with possible volatility of 6.876%.
Pessimistic target level: 0.29
Optimistic target level: 0.31
CYTO (CYTO) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| May. | 0.34 | 0.33 | 0.39 | 17.24 |
| Jun. | 0.37 | 0.33 | 0.40 | 17.41 |
| Jul. | 0.35 | 0.32 | 0.38 | 17.59 |
| Aug. | 0.28 | 0.25 | 0.31 | 18.80 |
| Sep. | 0.27 | 0.24 | 0.29 | 16.30 |
| Oct. | 0.29 | 0.25 | 0.32 | 21.12 |
| Nov. | 0.28 | 0.27 | 0.31 | 15.43 |
| Dec. | 0.27 | 0.23 | 0.29 | 23.18 |
Altamira Therapeutics forecast for this year
Altamira Therapeutics Stock Prediction for May 2025
An uptrend is forecast for this month with an optimal target price of $0.3396. Pessimistic: $0.33. Optimistic: $0.39
Altamira Therapeutics Stock Prediction for Jun 2025
An uptrend is forecast for this month with an optimal target price of $0.368806. Pessimistic: $0.33. Optimistic: $0.40
Altamira Therapeutics Stock Prediction for Jul 2025
An downtrend is forecast for this month with an optimal target price of $0.354791. Pessimistic: $0.32. Optimistic: $0.38
Altamira Therapeutics Stock Prediction for Aug 2025
An downtrend is forecast for this month with an optimal target price of $0.283833. Pessimistic: $0.25. Optimistic: $0.31
Altamira Therapeutics Stock Prediction for Sep 2025
An downtrend is forecast for this month with an optimal target price of $0.2651. Pessimistic: $0.24. Optimistic: $0.29
Altamira Therapeutics Stock Prediction for Oct 2025
An uptrend is forecast for this month with an optimal target price of $0.286308. Pessimistic: $0.25. Optimistic: $0.32
Altamira Therapeutics Stock Prediction for Nov 2025
An downtrend is forecast for this month with an optimal target price of $0.28459. Pessimistic: $0.27. Optimistic: $0.31
Altamira Therapeutics Stock Prediction for Dec 2025
An downtrend is forecast for this month with an optimal target price of $0.268653. Pessimistic: $0.23. Optimistic: $0.29
Altamira Therapeutics (CYTO) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 0.28 | 0.25 | 0.32 | 21.13 |
| Feb | 0.29 | 0.27 | 0.34 | 20.28 |
| Mar | 0.24 | 0.23 | 0.26 | 13.32 |
| Apr | 0.20 | 0.18 | 0.23 | 21.97 |
| May | 0.22 | 0.21 | 0.23 | 11.03 |
| Jun | 0.24 | 0.20 | 0.25 | 20.97 |
| Jul | 0.23 | 0.20 | 0.26 | 21.04 |
| Aug | 0.27 | 0.24 | 0.29 | 18.36 |
| Sep | 0.24 | 0.20 | 0.26 | 22.32 |
| Oct | 0.28 | 0.25 | 0.32 | 21.29 |
| Nov | 0.27 | 0.23 | 0.29 | 19.93 |
| Dec | 0.23 | 0.21 | 0.25 | 18.23 |
Altamira Therapeutics (CYTO) Monthly Stock Prediction for 2027
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 0.22 | 0.21 | 0.24 | 13.67 |
| Feb | 0.23 | 0.21 | 0.26 | 20.84 |
| Mar | 0.19 | 0.18 | 0.20 | 9.75 |
| Apr | 0.21 | 0.18 | 0.23 | 21.58 |
| May | 0.23 | 0.21 | 0.24 | 11.47 |
| Jun | 0.24 | 0.23 | 0.28 | 17.89 |
| Jul | 0.22 | 0.21 | 0.25 | 18.25 |
| Aug | 0.19 | 0.17 | 0.20 | 13.47 |
| Sep | 0.19 | 0.17 | 0.19 | 11.15 |
| Oct | 0.16 | 0.14 | 0.18 | 25.18 |
| Nov | 0.14 | 0.13 | 0.16 | 22.38 |
| Dec | 0.16 | 0.15 | 0.19 | 21.49 |
Altamira Therapeutics information and performance
N/A
Market capitalization of the Altamira Therapeutics Ltd. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of CYTO shares in the company outstanding by the market price of one share.
EBITDA of Altamira Therapeutics is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
FAQ (Frequently Asked Questions about Altamira Therapeutics Stock)
Should I Buy Altamira Therapeutics Shares in 2025 year?
Does Altamira Therapeutics pay dividends?
Which economic sector do Altamira Therapeutics's shares belong to?
Which other securities belong to the same sector as Altamira Therapeutics's shares?
Related stocks from Healthcare sector
